These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24013519)

  • 61. Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor.
    Sayer HG; Kröger M; Beyer J; Kiehl M; Klein SA; Schaefer-Eckart K; Schwerdtfeger R; Siegert W; Runde V; Theuser C; Martin H; Schetelig J; Beelen DW; Fauser A; Kienast J; Höffken K; Ehninger G; Bornhäuser M;
    Bone Marrow Transplant; 2003 Jun; 31(12):1089-95. PubMed ID: 12796788
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The prevalence and prognostic value of concomitant eosinophilia in chronic graft-versus-host disease after allogeneic stem cell transplantation.
    Mortensen KB; Gerds TA; Bjerrum OW; Lindmark A; Sengeløv H; Andersen CL
    Leuk Res; 2014 Mar; 38(3):334-9. PubMed ID: 24439053
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Is reduced-intensity conditioning the standard of care in the transplant setting?
    Giralt SA
    Clin Adv Hematol Oncol; 2008 May; 6(5):337-9. PubMed ID: 18516022
    [No Abstract]   [Full Text] [Related]  

  • 64. High alloreactivity of low-dose prophylactic donor lymphocyte infusion in patients with acute leukemia undergoing allogeneic hematopoietic cell transplantation with an alemtuzumab-containing conditioning regimen.
    Liga M; Triantafyllou E; Tiniakou M; Lambropoulou P; Karakantza M; Zoumbos NC; Spyridonidis A
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):75-81. PubMed ID: 22871557
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy.
    Cook G; Clark RE; Crawley C; Mackinnon S; Russell N; Thomson K; Pearce RM; Towlson K; Marks DI
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):293-300. PubMed ID: 16503498
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Intravenous busulfan-cyclophosphamide as a preparative regimen before allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia.
    Tang W; Wang L; Zhao WL; Chen YB; Shen ZX; Hu J
    Biol Blood Marrow Transplant; 2011 Oct; 17(10):1555-61. PubMed ID: 21549217
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation.
    Oran B; Giralt S; Couriel D; Hosing C; Shpall EJ; de Meis E; Khouri IF; Qazilbash M; Anderlini P; Kebriaei P; Popat U; Carrasco-Yalan A; Champlin RE; de Lima M
    Leukemia; 2007 Dec; 21(12):2540-4. PubMed ID: 17611563
    [No Abstract]   [Full Text] [Related]  

  • 68. CMV and relapse: what has conditioning to do with it?
    Elmaagacli AH
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):1-2. PubMed ID: 24216183
    [No Abstract]   [Full Text] [Related]  

  • 69. T-cell lymphoma with immune-mediated anemia and thrombocytopenia in a horse.
    McGovern KF; Lascola KM; Davis E; Fredrickson RL; Tan R
    J Vet Intern Med; 2011; 25(5):1181-5. PubMed ID: 21985147
    [No Abstract]   [Full Text] [Related]  

  • 70. Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation.
    Buxbaum NP; Pavletic SZ
    Front Immunol; 2020; 11():2017. PubMed ID: 32983144
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intra-Arterial Platelet Infusion for Intractable Hemorrhage and Refractory Thrombocytopenia in Children With Gastrointestinal Graft-Versus-Host Disease.
    Kably IM; Ziga ED; Andreansky M
    Pediatr Blood Cancer; 2015 Dec; 62(12):2226-8. PubMed ID: 26179050
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Successful control of steroid-intolerant Evans' syndrome associated with allogeneic peripheral blood hematopoietic stem cell transplant by rituximab.
    Ryeon Lee S; Lee SY; Nam MH; Park Y; Jong Park S; Jung Sung H; Won Choi C; Soo Kim B
    Leuk Lymphoma; 2011 Mar; 52(3):528-30. PubMed ID: 21275632
    [No Abstract]   [Full Text] [Related]  

  • 73. Graft versus host disease localized to striae distensae: An example of locus minoris resistentiae.
    Bishnoi A; Lad D; Ashraf R; Banerjee N; Saikia UN; Vinay K
    Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):555-557. PubMed ID: 33871201
    [No Abstract]   [Full Text] [Related]  

  • 74. Tuberculosis cutis orificialis: an association with Evans' syndrome.
    Kim SW; Choi SW; Cho BK; Houh W; Lee JW
    Acta Derm Venereol; 1995 Jan; 75(1):84-5. PubMed ID: 7747548
    [No Abstract]   [Full Text] [Related]  

  • 75. Polymyositis: a manifestation of chronic graft-versus-host disease.
    Prussick R; Brain MC; Walker IR; Sauder DN
    J Am Acad Dermatol; 1991 Sep; 25(3):560-2. PubMed ID: 1918495
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hemorrhagic hepatic cyst after allogeneic bone marrow transplantation.
    Kato S; Konuma T; Tojo A; Takahashi S
    Int J Hematol; 2014 Sep; 100(3):214-5. PubMed ID: 25037268
    [No Abstract]   [Full Text] [Related]  

  • 77. Management of refractory autoimmune hemolytic anemia via allogeneic stem cell transplantation.
    Rotenstein L; Nathan A; Ghobrial I; Antin J; Parnes A
    Bone Marrow Transplant; 2016 Nov; 51(11):1504-1506. PubMed ID: 27272445
    [No Abstract]   [Full Text] [Related]  

  • 78. Evans syndrome with auto-immune neutropenia.
    Bilochvostenko MA; Ermens AAM; Fiets RB
    Int J Lab Hematol; 2022 Feb; 44(1):61-62. PubMed ID: 34228400
    [No Abstract]   [Full Text] [Related]  

  • 79. Chronic graft-versus-host disease.
    Margolis J; Vogelsang G
    J Hematother Stem Cell Res; 2000 Jun; 9(3):339-46. PubMed ID: 10894355
    [No Abstract]   [Full Text] [Related]  

  • 80. Rapidly fatal post-allogeneic stem cell transplant lymphoproliferative disorder presenting with skin and bone marrow involvement.
    Gasiorowski R; Gibson J; Watson G; Trotman J; Larsen S
    Pathology; 2013 Jan; 45(1):81-3. PubMed ID: 23255032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.